Disagree
Home Dragon Pharma Dragon Pharma
Mazdutide
Mazdutide - Dragon Pharma

Mazdutide - Dragon Pharma

Brand:
Category:
Substance:
Package:
10 mg
Price:
$100.00 - $180.00
See options
Product Overview

IBI362 also called Mazdutide, is a dual GLP-1 and glucagon receptor agonist that targets obesity and its related health issues, such as type 2 diabetes. Reduces food intake and increases energy usage, promoting effective weight loss. Regulating blood sugar levels. Indicating its promise as a therapy for people with diabetes and those, without.

References:

Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Mazdutide by Dragon Pharma, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Who can use Mazdutide?
Individuals with obesity, with or without diabetes.
References:

Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/

Are there studies on Mazdutide(IBI362) effectiveness?
Yes multiple trials show positive results for weight loss.
References:

Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/

What makes Mazdutide(IBI362) different from other treatments?
Its dual-action targets weight and blood sugar simultaneously.
References:

Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/